UBS Initiates Coverage On Wave Life Sciences with Buy Rating, Announces Price Target of $11
UBS analyst Joon Lee initiates coverage on Wave Life Sciences (NASDAQ:WVE) with a Buy rating and announces Price Target of $11.
Share
Why It Matters
A big bank's analyst says Wave Life Sciences looks like a good company to own. When a trusted analyst starts watching a stock, it means they think the company might do well.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.